Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 7169791 Inhibitors of tyrosine kinases

Patent 7169791 was granted and assigned to Novartis on January, 2007 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributorsActivity
Is a
Patent
Patent
0
Current Assignee
Novartis
Novartis
0
Date Filed
July 4, 2003
0
Date of Patent
January 30, 2007
0
Patent Application Number
10520359
0
Patent Citations Received
‌
US Patent 12016861 Amorphous nilotinib microparticles and uses thereof
0
‌
US Patent 12064428 Kinase inhibitor salts and compositions thereof
0
‌
US Patent 12064430 Kinase inhibitor salts and compositions thereof
0
‌
US Patent 11708412 Methods for treating hematologic cancers
0
‌
US Patent 11998548 Amorphous nilotinib microparticles and uses thereof
0
‌
US Patent 11827704 Antibody molecules to PD-1 and uses thereof
0
Patent Inventor Names
Pascal Furet
0
Paul William Manley
0
Sandra Jacob
0
Werner Breitenstein
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
7169791
0
Patent Primary Examiner
‌
Deepak Rao
0

Find more entities like US Patent 7169791 Inhibitors of tyrosine kinases

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo
By using this site, you agree to our Terms of Service.